US FDA News: FDA approves first treatment for pediatric patients with lupus

FDA approves Benlysta for treatment of children with systemic lupus erythematosus (SLE), a chronic disease causing inflammation and damage to tissue and organs
Read more: FDA approves first treatment for pediatric patients with lupus